MAXXCARE COMPANY LIMITED — Glimepiride Importer Profile
Pharmaceutical Importer · #11 buyer for Glimepiride · $735.1K import value · 22 shipments · VIETNAM DEMOCRATIC REP. OF · DGFT Verified
MAXXCARE COMPANY LIMITED is the #11 importer of Glimepiride from India with $735.1K in import value and 22 verified shipments. MAXXCARE COMPANY LIMITED holds a 0.6% market share in Glimepiride imports based in VIETNAM DEMOCRATIC REP. OF. The company sources from 1 verified supplier across 15 formulations shipped to 3 countries. Overall, MAXXCARE COMPANY LIMITED imports 2 pharmaceutical products worth $1.9M across 2 therapeutic categories.
MAXXCARE COMPANY LIMITED — Glimepiride Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Glimepiride to MAXXCARE COMPANY LIMITED?
Verified from 22 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INVENTIA HEALTHCARE LIMITED | $735.1K | 22 | 100.0% |
MAXXCARE COMPANY LIMITED sources Glimepiride from 1 verified Indian supplier based on 22 customs records. The primary supplier is INVENTIA HEALTHCARE LIMITED accounting for 100.0% of imports.
How Does MAXXCARE COMPANY LIMITED Compare to Nearest Glimepiride Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $600.0K | 12 | $50.0K |
| 10 | I.E. MEDICA INC. | PHILIPPINES | $574.6K | 15 | $38.3K |
| 11 | MAXXCARE COMPANY LIMITED ★ | VIETNAM | $476.0K | 13 | $36.6K |
| 12 | BROWN AND BURK PHILIPPINES INC | PHILIPPINES | $460.0K | 13 | $35.4K |
| 14 | ZENTIVA SA ROMANIA | ROMANIA | $443.2K | 15 | $29.5K |
MAXXCARE COMPANY LIMITED ranks #11 among 535 Glimepiride importers from India. Average shipment value of $36.6K compared to the market average of $17.0K. The closest competitors by value are AJANTA PHARMA PHILIPPINES INC and I.E. MEDICA INC..
Where Does MAXXCARE COMPANY LIMITED Import Glimepiride To?
Destination countries from 22 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM DEMOCRATIC REP. OF | $434.4K | 13 | 59.1% |
| VIETNAM | $244.0K | 5 | 33.2% |
| VIETNAM, DEMOCRATIC REP. OF | $56.7K | 4 | 7.7% |
MAXXCARE COMPANY LIMITED imports Glimepiride to 3 countries. The primary destination is VIETNAM DEMOCRATIC REP. OF receiving 59.1% of shipments worth $434.4K.
What Glimepiride Formulations Does MAXXCARE COMPANY LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| PERGLIM M -2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & METFORMIN HCL BP 500MG)NOS | $150.0K | 3 |
| PERGLIM M -1 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 1 MG & METFORMIN HCL BP 500MG) AS PER INVNOS | $114.8K | 3 |
| PERGLIM M-2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & METFORMIN HCl BP 500 MG) | $97.8K | 2 |
| PERGLIM M -1 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 1 MG & METFORMIN HCL BP 500 MG) AS PER INVNOS | $69.1K | 3 |
| PERGLIM M-2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & METFORMIN HCl BP 500 MG) | $50.0K | 1 |
| PERGLIM M-2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & METFORMIN HCl BP 500 MG) PACK: 5X20 | $50.0K | 1 |
| PERGLIM M -2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & METFORMIN HCL BP 500 MG) AS PER INVNOS | $48.1K | 1 |
| PHARMA : PERGLIM M-1 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 1MG & METFORMIN HCI BP 500MG) - 01 NOS = 5x20 TABS | $46.1K | 1 |
| PERGLIM M-1 -(EACH TABLET CONTAIN:GLIMEPIRIDE USP 1 MG & METFORMIN HCL BP 500 MG) | $46.1K | 1 |
| PERGLIM M -1(EACH TABLET CONTAIN GLIMEPIRIDE USP 1 MG & METFORMIN HCL BP 500 MG)( PACK SIZE5X20)(NOS=CARTONS)NOS | $45.3K | 1 |
MAXXCARE COMPANY LIMITED imports 15 distinct Glimepiride formulations from India. The top formulation is PERGLIM M -2 (EACH TABLET CONTAIN: GLIMEPIRIDE USP 2 MG & M with 3 shipments worth $150.0K.
Who Are the Top Buyers of Glimepiride from India and How Much Does MAXXCARE COMPANY LIMITED Import?
India exported $9.1M worth of Glimepiride through 3,159 shipments from 242 suppliers to 94 countries, serving 535 buyers globally. MAXXCARE COMPANY LIMITED imports $735.1K of this total, accounting for 0.6% of India's Glimepiride exports with 22 shipments from VIETNAM DEMOCRATIC REP. OF. This is verified from 22 customs shipment records covering 15 distinct formulations.
What Is the Average Order Value for MAXXCARE COMPANY LIMITED's Glimepiride Imports?
MAXXCARE COMPANY LIMITED's average Glimepiride order value is $33.4K per consignment, based on 22 shipments totaling $735.1K. MAXXCARE COMPANY LIMITED is based in VIETNAM DEMOCRATIC REP. OF and ranks #11 among all Glimepiride importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Glimepiride to MAXXCARE COMPANY LIMITED?
MAXXCARE COMPANY LIMITED sources Glimepiride from 1 verified Indian supplier: INVENTIA HEALTHCARE LIMITED ($735.1K, 100.0%). This is based on 22 customs records.
How Does MAXXCARE COMPANY LIMITED Compare to Other Glimepiride Importers?
MAXXCARE COMPANY LIMITED ranks #11 among 535 Glimepiride importers from India with a 0.6% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES, LLC ($1.3M), EVERSANA LIFE SCIENCE SERVICES LLC ($905.2K), APL SWIFT SERVICES (MALTA) LTD., ($780.5K). MAXXCARE COMPANY LIMITED processed 22 shipments from VIETNAM DEMOCRATIC REP. OF.
About MAXXCARE COMPANY LIMITED
MAXXCARE COMPANY LIMITED imports 2 products worth $1.9M. Beyond Glimepiride, top products include Amphotericin. View the complete MAXXCARE COMPANY LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glimepiride — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MAXXCARE COMPANY LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MAXXCARE COMPANY LIMITED's capped import value divided by total capped export value for Glimepiride across all Indian exporters.
- 5.Verified Records: This page is backed by 22 individual customs records matching MAXXCARE COMPANY LIMITED importing Glimepiride, covering 15 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 535+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glimepiride Import Data for MAXXCARE COMPANY LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for MAXXCARE COMPANY LIMITED's Glimepiride imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MAXXCARE COMPANY LIMITED
Full Company Profile →
2 products · $1.9M total trade · 2 categories
MAXXCARE COMPANY LIMITED × Glimepiride
Verified from customs records
Company Overview
Top Products by MAXXCARE COMPANY LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MAXXCARE COMPANY LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glimepiride. For current order-level data, contact TransData Nexus.